Evaluation of subretinal fluid absorption by optical coherence tomography in circumscribed choroidal hemangioma after photodynamic therapy with Verteporfin

Neuroendocrinology Letters

Volumn 25, Issue 1-2, 2004, Pages 109-114

  Soucek, Petr ^a,b   Cihelková, Ilona ^a  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

Author keywords

Circumscribed choroidal hemangioma; Optical coherence tomography; Photodynamic therapy; Retinal thickness at fixation point; Subretinal fluid absorption; Verteporfin

Indexed keywords

BENZOPORPHYRIN DERIVATIVE; PHOTOSENSITIZING AGENT; PORPHYRIN;

ANIMAL MODEL; ARTICLE; BIOMICROSCOPY; CHOROID DISEASE; DOSE RESPONSE; FLUORESCENCE ANGIOGRAPHY; FOLLOW UP; HEMANGIOMA; INDOCYANINE GREEN ANGIOGRAPHY; LASER; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PHOTODYNAMIC THERAPY; SUBRETINAL FLUID; TREATMENT OUTCOME; ADULT; AGED; BODY FLUID; CHOROID TUMOR; CLINICAL TRIAL; DRUG EFFECT; FEMALE; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; PATHOLOGY; PHOTOCHEMOTHERAPY; RETINA; RETINA FOVEA;

ADULT; AGED; BODY FLUIDS; CHOROID NEOPLASMS; FEMALE; FOVEA CENTRALIS; HEMANGIOMA; HUMANS; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; PORPHYRINS; RETINA; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME;

EID: 3242806759     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Ip MS, Baker BJ, Duker JS et al. Anatomical Outcomes of Surgery for Idiopathic Macular Hole as determined by Optical Coherence Tomography. Arch Ophthalmol 2002; 120:29-35.
2. Massin P, Vicaut E, Haouchine B et al. Reproducibility of retinal Mapping Using Optical Coherence Tomography. Arch Ophthalmol 2001; 119:1135-42.
3. Cihelkova I, Soucek P. Nalezy na opticke koherentni tomografii u pacientu s makularni degeneraci lecenych pomoci fotodynamicke terapie s preparatem Visudyne. [(Findings on Optical Coherence Tomography in Macular Degeneration with Predominantly Classic Subfoveal Choroidal Neovascularization Terated by Photodynamic Therapy with Visudyne.) (In Czech with English abstract.)] Ces a slov Oftal 2003; 59:250-6.
4. Schmidt-Erfurth U, Hasan T. Mechanisms of Action of Photodynamic Therapy with Verteporfin for the Treatment of Age-Related Macular Degeneration. Surv Ophthalmol 2000; 45:195-214.
5. Keam SJ, Scott LJ, Curran MP. Verteporfin: a review of its use in the management of subfoveal choroidal neovascularisation. Drugs 2003; 63:2521-54.
6. Bakri SJ, Kaiser PK. Verteporfin ocular photodynamic therapy. Expert Opin Phramacother 2004; 5:195-203.
7. Witschel H, Font RL. Hemangioma of the choroid. A clinicopathologic study of 71 cases and a review of literature. Surv Ophthalmol 1976; 20:415-31.
8. Shields CL, Honavar SG, Shields JA et al. Circumscribed Choroidal Hemangioma. Clinical Manifestation and Factors Predictive of Visual Outcome in 200 Consecutive Cases. Ophthalmology 2001; 108:2237-48.
9. Mashayekhi A, Shields, CL. Circumscribed choroidal hemangioma. Curr Opin in Ophthalmol 2003; 14:142-9.
10. Jurklies B, Anastassiou G, Ortmans S. et al. Photodynamic therapy using Verteporfin in circumscribed choroidal haemangioma. Br J Ophthalmol 2003; 87:84-9.
11. Porrini G, Giovannini A, Amato G et al. Photodynamic Therapy of Circumscribed Choroidal Hemangioma. Ophthalmology 2003; 110:674-80.
12. Landau IME, Steen B, Seregard S. Photodynamic therapy for circumscribed choroidal haemangioma. Acta Ophthalmol. Scand 2002; 80:531-6.
13. Schmidt-Erfurth U, Michels S, Kusserow C et al. Photodynamic Therapy for Symptomatic Choroidal Hemangioma. Ophthalmology 2002; 109:2284-94.
14. Robertson DM. Photodynamic Therapy for Choroidal Hemangioma Associated With Serous Retinal Detachment. Arch Ophthalmol 2002; 120:1155-61.
15. Madreperla SA. Choroidal Hemangioma Treated With Photodynamic Therapy Using Verteporfin. Arch Ophthalmol 2001; 119: 1606-10.
16. Barbazetto I, Schmidt-Erfurth U. Photodynamic therapy of choroidal hemangioma: two case reports. Graefe's Arch Clin Exp Ophthalmol 2000; 238:214-21.
17. Verbraak FD, Schlingemann RO, Keunen JEE et al. Longstanding symptomatic choroidal hemangioma managed with limited PDT as initial or salvage therapy. Graefe's Arch Clin Exp Ophthalmol 2003; 241:891-8.
18. Anand R. Photodynamic therapy for diffuse choroidal hemangioma associated with Sturge Weber syndrome. Am J Ophthalmol 2003; 136:758-60.
19. Schmidt-Erfurth UM, Kusserow C, Barbazetto IA et al. Benefits and Complications of Photodynamic Therapy of Papillary Capillary Hemangiomas. Ophthalmology 2002; 109:1256-66.
20. Barbazetto IA, Smith RT. Vasoproliferative tumor of the retina treated with PDT. Retina 2003; 23:565-7.
21. Messmer KJ, Abel SR. Verteporfin for age-related macular degeneration. Ann Pharmacother 2001; 35:193-8.
22. Soucek P, Boguszakova J, Cihelkova I. Fotodynamicka terapie s preparatem Visudyne u makularni degenerace se subfoveolarne ulozenou prevazne klasickou choroidalni neovaskularizad. [(Photodynamic therapy with Visudyne in Macular Degeneration with Subfoveal Predominantly Classic Choroidal Neovascularization.) (In Czech with English abstract.)] Ces a slov Oftal 2002; 58:89-97.
23. Ruby AJ, Jampol LM, Golberg MF et al. Choroidal neovascularization associated with choroidal hemangiomas. Arch Ophthalmol 1992; 110:658-61.
24. Soucek P, Cihelkova I. Treatment of macular degeneration (A controlled case). Neuroendocrinology Letters 2002; 23:370-2.
25. Sanborn GE, Augsburger JJ, Shields JA. Treatment of circumscribed choroidal hemangiomas. Ophthalmology 1982; 89: 1374-80.